Search Results for "Tenoretic"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Tenoretic. Results 1 to 3 of 3 total matches.

In Brief: Low-Dose Chlorthalidone (HemiClor) for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2025  (Issue 1733)
(Edarbyclor) and atenolol (Tenoretic, and generics).1,2 CHLORTHALIDONE — Chlorthalidone is more potent than ...
The FDA has approved a 12.5-mg tablet formulation of the thiazide-like diuretic chlorthalidone (HemiClor – Ingenus) for treatment of hypertension. Chlorthalidone has been available for years in 15-, 25-, and 50-mg tablets (Thalitone, and generics) and in fixed-dose combinations with azilsartan medoxomil (Edarbyclor) and atenolol (Tenoretic, and generics).
Med Lett Drugs Ther. 2025 Jul 21;67(1733):118   doi:10.58347/tml.2025.1733e |  Show IntroductionHide Introduction

Byvalson - A Beta Blocker/ARB Combination for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Sep 12, 2016  (Issue 1503)
-Adrenergic Blockers and Diuretics Atenolol/chlorthalidone 50/25, 100/25 mg tabs generic 197.20 Tenoretic ...
The FDA has approved Byvalson (Allergan), a fixed-dose combination of the beta blocker nebivolol (Bystolic) and the angiotensin receptor blocker (ARB) valsartan (Diovan, and generics), for treatment of hypertension. It is the only combination product that contains nebivolol, and the first to combine a beta blocker with an ARB.
Med Lett Drugs Ther. 2016 Sep 12;58(1503):115-7 |  Show IntroductionHide Introduction

Drugs for Hypertension

   
The Medical Letter on Drugs and Therapeutics • May 27, 2024  (Issue 1703)
/chlorthalidone 50/25, 100/25 mg tabs generic 32.00 Tenoretic (Almatica) 450.003 Beta-Adrenergic Blocker ...
American College of Cardiology/American Heart Association (ACC/AHA) guidelines for treatment of hypertension were last published in 2018. Treatment of hypertensive urgencies and emergencies is not discussed here.
Med Lett Drugs Ther. 2024 May 27;66(1703):81-8   doi:10.58347/tml.2024.1703a |  Show IntroductionHide Introduction